Social Research ¦ Market Research ¦ Behavioural Insight ¦ Evaluation ¦ SROI
Social Research ¦ Market Research ¦ Behavioural Insight ¦ Evaluation ¦ SROI
M·E·L Research have been commissioned by the Wales Cancer Network to help assess the outcomes and impact of the Rapid Diagnosis Clinics (RDC) programme.
The RDC programme is a national initiative supporting Health Boards in Wales to provide General Practitioners (GPs) with a referral pathway and RDC to investigate vague symptoms that may be caused by cancer. RDCs aim to:
• Support earlier diagnosis for patients with vague, non-specific symptoms that could be cancer
• Reduce cancer diagnoses via emergency presentations
• Improve overall patient health outcomes by detecting cancer earlier
• Improve patient and GP experience
• Identify and manage other serious non-malignant disease or those at risk of developing serious illness
• Provide reassurance and early discharge for those patients with no, or non-serious disease, thus increasing capacity through appropriate and efficient use of finite services
We will carry out a summative evaluation, using primary and secondary research evidence, to assess the impact of the programme and whether the above aims have been achieved. Although the RDC programme in Wales is a national programme, the approach has been adopted by taking into account the local context within all Health Boards operating an RDC. It is therefore crucial for us to capture the unique learning from each locality to support new developments and future rollout.
The evaluation is expected to start from March 2023 with the final evaluation report to be delivered in September 2023.
You can find out more about our health and wellbeing research and evaluation expertise here or to discuss a specific project please get in touch directly.
